Journal article
OK-432 Therapy for Lymphangiomas
Archives of otolaryngology--head & neck surgery, Vol.122(11), pp.1195-1199
11/01/1996
DOI: 10.1001/archotol.1996.01890230041009
PMID: 8906054
Abstract
OBJECTIVE: To assess the efficacy of OK-432 sclerotherapy in the treatment of lymphangiomas. DESIGN: Nonrandomized trial; follow-up, 4 to 29 months. SETTING: Academic tertiary referral medical center. PATIENTS: Six children with presumed lymphangiomas; age range at initial treatment, 1 month to 7 years 10 months. INTERVENTION: Fluoroscopically guided cyst aspiration, cystography, and injection of OK-432. OUTCOME MEASURES: Clinical and radiographic comparisons before and after therapy. RESULTS: Complete response in 2 macrocystic lymphangiomas; no response in 3 microcystic lymphangiomas; and no response in 1 venous malformation. CONCLUSION: OK-432 sclerotherapy may be effective treatment for macrocystic lymphangiomas.Arch Otolaryngol Head Neck Surg. 1996;122:1195-1199
Details
- Title: Subtitle
- OK-432 Therapy for Lymphangiomas
- Creators
- Richard J. H SmithDiane K BurkeYutaka SatoRolland I PoustKen KimuraNancy M Bauman
- Resource Type
- Journal article
- Publication Details
- Archives of otolaryngology--head & neck surgery, Vol.122(11), pp.1195-1199
- DOI
- 10.1001/archotol.1996.01890230041009
- PMID
- 8906054
- NLM abbreviation
- Arch Otolaryngol Head Neck Surg
- ISSN
- 0886-4470
- eISSN
- 1538-361X
- Publisher
- American Medical Association
- Language
- English
- Date published
- 11/01/1996
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Pharmacy; Molecular Physiology and Biophysics; Anatomy and Cell Biology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Surgery; Otolaryngology; Internal Medicine
- Record Identifier
- 9984006450802771
Metrics
17 Record Views